Eribulin and Confusion: A Previously Unknown Drug Side-Effect

Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman trea...

Full description

Bibliographic Details
Main Authors: Abu Baker Sheikh, Abhilash Perisetti, Nismat Javed, Rahul Shekhar
Format: Article
Language:English
Published: SMC MEDIA SRL 2020-06-01
Series:European Journal of Case Reports in Internal Medicine
Subjects:
Online Access:https://www.ejcrim.com/index.php/EJCRIM/article/view/1708
_version_ 1818043027165282304
author Abu Baker Sheikh
Abhilash Perisetti
Nismat Javed
Rahul Shekhar
author_facet Abu Baker Sheikh
Abhilash Perisetti
Nismat Javed
Rahul Shekhar
author_sort Abu Baker Sheikh
collection DOAJ
description Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.
first_indexed 2024-12-10T08:55:41Z
format Article
id doaj.art-0012887f0a494954a44cbc3870c2cccb
institution Directory Open Access Journal
issn 2284-2594
language English
last_indexed 2024-12-10T08:55:41Z
publishDate 2020-06-01
publisher SMC MEDIA SRL
record_format Article
series European Journal of Case Reports in Internal Medicine
spelling doaj.art-0012887f0a494954a44cbc3870c2cccb2022-12-22T01:55:26ZengSMC MEDIA SRLEuropean Journal of Case Reports in Internal Medicine2284-25942020-06-0110.12890/2020_0017081343Eribulin and Confusion: A Previously Unknown Drug Side-EffectAbu Baker Sheikh0Abhilash Perisetti1Nismat Javed2Rahul Shekhar3Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USADepartment of Gastroenterology, University of Arkansas for Medical Sciences, Little Rock, AR, USADepartment of Internal Medicine, Shifa College of Medicine, Islamabad, PakistanDepartment of Internal Medicine, University of New Mexico, Albuquerque, NM, USAEribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.https://www.ejcrim.com/index.php/EJCRIM/article/view/1708eribulinencephalopathybreast cancer
spellingShingle Abu Baker Sheikh
Abhilash Perisetti
Nismat Javed
Rahul Shekhar
Eribulin and Confusion: A Previously Unknown Drug Side-Effect
European Journal of Case Reports in Internal Medicine
eribulin
encephalopathy
breast cancer
title Eribulin and Confusion: A Previously Unknown Drug Side-Effect
title_full Eribulin and Confusion: A Previously Unknown Drug Side-Effect
title_fullStr Eribulin and Confusion: A Previously Unknown Drug Side-Effect
title_full_unstemmed Eribulin and Confusion: A Previously Unknown Drug Side-Effect
title_short Eribulin and Confusion: A Previously Unknown Drug Side-Effect
title_sort eribulin and confusion a previously unknown drug side effect
topic eribulin
encephalopathy
breast cancer
url https://www.ejcrim.com/index.php/EJCRIM/article/view/1708
work_keys_str_mv AT abubakersheikh eribulinandconfusionapreviouslyunknowndrugsideeffect
AT abhilashperisetti eribulinandconfusionapreviouslyunknowndrugsideeffect
AT nismatjaved eribulinandconfusionapreviouslyunknowndrugsideeffect
AT rahulshekhar eribulinandconfusionapreviouslyunknowndrugsideeffect